Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article

Nardin Wagih1, Islam M Abdel-Rahman1, Nawal A El-Koussi1,2

  • 1Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University New Minia 61111 Egypt gamalaburahma@yahoo.com.

RSC Advances
|January 14, 2025
PubMed

Insights

Benzimidazole derivatives show promise as targeted cancer therapies by modulating epigenetic changes. These compounds offer a potential strategy for developing less toxic treatments and improving patient outcomes.

Area of Science:

  • Oncology
  • Epigenetics
  • Medicinal Chemistry

Background:

  • Cancer remains a major global health challenge, with epigenetic dysregulation significantly contributing to its development and progression.
  • Epigenetic modifications, which alter gene expression without changing DNA sequence, are increasingly recognized as critical therapeutic targets.
  • Targeting epigenetic mechanisms offers a promising avenue for developing novel, less toxic cancer treatments.

Purpose of the Study:

  • To provide a comprehensive review of benzimidazole derivatives as epigenetic modulators in cancer therapy.
  • To highlight the therapeutic potential of benzimidazole derivatives targeting DNA methyltransferases, histone deacetylases, and histone methyltransferases.
  • To emphasize recent advancements and future directions for benzimidazole-based epigenetic drugs in oncology.

Main Methods:

  • Literature review focusing on benzimidazole derivatives and their interaction with epigenetic targets (readers, writers, erasers).
  • Analysis of studies investigating the efficacy of benzimidazole derivatives in preclinical and clinical cancer models.
  • Synthesis of information on the mechanisms of action and therapeutic potential of these compounds.

Main Results:

  • Benzimidazole derivatives exhibit potent inhibition of key epigenetic targets involved in cancer.
  • Several promising benzimidazole derivatives are advancing through clinical trials for hematological and solid malignancies.
  • These compounds demonstrate potential for developing targeted, less toxic cancer therapies.

Conclusions:

  • Benzimidazole derivatives represent a valuable class of epigenetic agents for cancer treatment.
  • Further research into benzimidazole derivatives could lead to the design of multi-target drugs to overcome resistance and improve clinical outcomes.
  • This review serves as a resource for researchers developing novel anticancer benzimidazole derivatives with enhanced properties.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...